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Final Report: Effects of Simulated Weightlessness
On Regional Blood Flow Specifically
During Cariovascular Stress
Significant changes in the cardiovasular system of humans and animals have
been observed following exposure to prolonged periods of weightlessness during
space flight. Although adaption to weightlessness is relatively uncompli-
cated, marked changes in cardiovascular deconditioning become evident upon
return to normal gravity, including orthostatic hypotension and tachycardia.
Some evidence that myocardial degeneration occurs has been demonstrated in
animals who have been immobilized for two months. Also, evidence of possible
loss of myocardial mass following manned space flight has been obtained by
means of echocardiographic studies.
These findings have serious implications in light of the increasing frequency
and duration of Space Shuttle missions and the prospect of extended space sta-
tion missions in the future. A number of both military and civilian inves-
tigators, including middle-aged scientists, will probably encounter prolonged
periods of weightlessness. It has been imperative, therefore, to determine
the effects of prolonged weightlessness on cardiovascular deconditioning and
whether such effects are cummulative or reversible questions.
The research project conducted under NASA Cooperative Agreement NCC 2-126 was
undertaken to determine the effects of prolonged simulated weightlessness on
regional blood flow. Research results are reported in the following publica-
tions which are incorporated here for reference:
1. Clusin, W.T.; Buchbinder, M.; Ellis, A.K.; Kernoff, R.S.;
Giacomini, J.C.; Harrison, D.C.: Reduction of Ischemic
Depolarization by the Calcium Channel Blocker Diltiazem.
Correlation with Improvement of Ventricular Conduction
and Early Arrhythmias in the Dog. Circulation Research
54(1): 10-20, January 1984.
2. Clusin, W.T.; Buchbinder, M.; Ellis, A.K.; Kernoff, R.S.;
Giacomini, J.C.; Harrison, D.C.: Reduction of Ischemic
Depolarization by Diltiazen: A Flow-Independent Effect.
Circulation 68(2): 111-22, 1983.
3. Ellis, A.K.; Giacomini, J.C.; Kernoff, R.S.; Harrison, D.C.:
Effects of Increased Right Ventricular Pressure on Coronary
Blood Flow Distribution. Federation Proceedings 42(4): 1002,
1983.
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deduction of Ischemic Depolarization by the Calcium
Channel Blocker Diltiazem
Correlation with Improvement of Ventricular Conduction and Early
Arrhythmias in the Dog
William T. Clusin, Maurice Buchbinder, Avery K. Ellis, Robert S. Kemoff, John C. Giacomini,
and Donald C. Harrison
From the Division of Cardiology, Stanford University School of Medicine, Stanford, California
SUMMARY. Calcium channel blockers suppress early ischemic arrhythmias, possibly by dimin-
ishing intracellular calcium overload and its effects on the ventricular action potential. To explore
this, we compared the effects of diltiazem on ischemic 'injury* potentials and ventricular
fibrillation during serial coronary artery occlusions in dogs. Injury potentials and ventricular
fibrillation were elicited every 15-25 minutes by simultaneous occlusion of the left anterior
descending and circumflex arteries during rapid atrial pacing. DC epicardial electrograms were
recorded differentially between the ischemic region and a small nonischemic region supplied by
a proximal branch of the left anterior descending artery. Injury potentials developed with a
uniform time course during five control occlusions, but were reduced by diltiazem infusion (0.5
mg/kg over 25 minutes) in each of eight dogs. The mean diastolic injury potential (T-Q depression)
at 150 seconds of ischemia was 9.1 ± 2.7 mV before diltiazem and 6.1 ± 1.6 mV afterward (P <
0.001). Diltiazem increased the mean time between coronary occlusion and ventricular fibrillation
from 186 to 366 seconds (P < 10~5), but did not change the magnitude of the diastolic injury
potential at onset of ventricular fibrillation. Diltiazem also delayed ischemia-induced conduction
impairment to the same extent that it delayed injury potential development. In five dogs, the
effect of diltiazem on regional blood flow near the epicardial electrodes was measured by infusion
of radionuclide-labeled microspheres. Coronary occlusion reduced flow to the ischemic zone from
0.86 to 0.05 ml/min per g (P = 0.001). Diltiazem increased preocclusion flow by 11% (P = 0.03),
but did not significantly alter flow during occlusion. Hemodynamic measurements show that
diltiazem did not diminish cardiac work. Diltiazem therefore produced a flow-independent
reduction of cellular depolarization during ischemia, which may be due to relief of calcium
overload, and which may explain the antifibrillatory effect. (CircRes 54:10-20,1984)
AN important property of calcium channel blockers
is their ability to delay or prevent early ischemic
arrhythmias during coronary artery occlusion. This
phenomenon was first described by Kaumann and
Aramendia in 1968, and has been confirmed in
subsequent studies involving verapamil (Huang and
Peng, 1977; Elharrar et al., 1977; Fondacaro et al,
1978; Brooks et al., 1980; Thandroyen, 1982), D-
600 (Schoenebeger et al., 1979), diltiazem (Clusin et
al., 1982; Thandroyen, 1982), nifidipene (Than-
droyen, 1982), and several other dihydropyridines
(Fagbemi and Parratt, 1981). The effects of calcium
channel blockers on ischemic arrhythmias may shed
light on the mechanisms by which these arrhythmias
arise. Inward current carried by calcium has been
suspected of mediating arrhythmias for many years
(Cranefield, 1975). More recently, abnormal eleva-
tion of intracellular calcium has been shown to
depolarize cardiac cells through direct effects on
membrane permeability (Kass et al., 1978a, 1978b;
Colquhoun et al., 1981; Matsuda et al., 1982; Clusin,
1983a, 1983b). Like older anti-anginal agents, cal-
cium channel blockers reduce the 'injury* currents,
that are probably involved in initiating ischemic
arrhythmias (Katzung et al., 1975; JQeber et al.,
1978; Janse et al., 1980). This effect is usually as-
cribed to a decrease in the extent or severity of
ischemia as a result of increased coronary perfusion,
or reduced expenditure of energy as mechanical
work. However, calcium channel blockers would
also reduce injury currents if the effects of ischemia
on the ventricular resting or action potential were a
direct consequence of intracellular calcium overload
(Clusin et al., 1983).
The study of arrhythmias is simplified if they can
be elicited reproducibly during multiple trials in the
same animal. We have previously found that simul-
taneous occlusion of the proximal LAD and circum-
flex arteries of the dog during rapid pacing induces
ventricular fibrillation (VF) swiftly and predictably
during successive trials (Clusin et al., 1982). The
time between vessel occlusion and the onset of VF—
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theVF latency—remains constant during as many
as 15 consecutive control occlusions, but is markedly
increased by infusion of diltiazem. This effect ap-
pears to be a direct result of reduced calcium influx
into myocardial cells, because there is no associated
increase in postocclusion coronary venous flow, and
no reduction of left ventricular work. VF latency is
also increased by infusion of sodium citrate, which
reduces serum ionized calcium.
Through a simple modification of the above tech-
nique, we can now correlate arrhythmia onset with
ischemia-induced changes in the ventricular action
potential and conduction. This is accomplished by
recording epicardial electrograms differentially be-
tween the ischemic portion of the left ventricle, and
a small region that deliberately is not made ischemic.
We obtain stable, high-amplitude records of is-
chemia-induced T-Q depression and S-T elevation,
which has previously been possible only in small
infarcts, where arrhythmias are not reproducible.,
ischemic injury potentials and conduction impair-
ment develop with a uniform time course during
successive control occlusions, but their appearance
is markedly slowed by diltiazem. These effects are
closely correlated with changes in VF latency, and
are not due to an increase in collateral coronary
perfusion. The beneficial electrophysiologjcal effects
of calcium channel blockade may therefore be di-
rectly ascribable to reduction of intracellular calcium
overload.
Methods
Healthy fasting mongrel dogs weighing 18-29 kg were
sedated with morphine sulfate (2 mg/kg, intramuscularly)
and anesthestized with intravenous chloralose (85 mg/
kg) and urethane (625 mg/kg). Ventilation was provided
by a Harvard pump, which delivered room air through a
cuffed endotracheal tube. Aortic blood pressure was meas-
ured by a Statham P23Db transducer connected to a large-
bore catheter inserted via the left femoral artery. A second
catheter was placed in the left internal jugular vein for
administration of additional anesthetics and experimental
drug. Depth and rate of respiration were adjusted to
maintain arterial pH between 7.35 and 7.45, Poi between
80 and 110 mm Hg, and Pcoj between 35 and 45 mm Hg.
The heart was exposed through an incision in the left
4th intercostal space. A bipolar hook electrode was at-
tached to the right atrium and connected to a WPI 800
series stimulator which delivered 2-msec current pulses at
twice diastolic threshold.. The proximal left anterior de-
scending (LAD) and circumflex coronary arteries were
exposed by dissection. Simultaneous reversible occlusion
of these arteries was performed every 15-25 minutes,
using nylon snares. The circumflex artery was occluded
within 1 cm of its origin, while the LAD was occluded just
beyond its first diagonal branch, leaving a small nonis-
chemic region (perfused zone). All occlusions were per-
formed during atrial pacing at a rate of 180-220 beats/
ruin. Data collection began with the second occlusion, so
that the preocclusion hemodynamics would be compara-
ble during- successive control trials (Clusin et al., 1982).
When VF occurred, pacing was discontinued, both snares
were released, cardiac massage was instituted for 1 min-
ute, and the animal was defibrillated using a 40-100 )
pulse supplied by a Hewlett-Packard model 780 2C defi-
brillator with 5-on paddles. The coronary snares were also
released after several trials in which VF failed to occur
within an arbitrary time limit of 420 seconds, owing to
prior infusion of diltiazem. In rare instances, experiments
were aborted because VF failed to occur within 240 sec-
onds during the control trials.
DC epicardial electrograms were recorded using a pair
of Ag/AgCl ECG electrode pellets (IM1, Inc.), that were
sutured to the heart through holes drilled in their plastic
casings, and connected to the inputs of a differential
amplifier. Each pellet was 5 mm in diameter, and was
coated with NaCl-containing electrode jelly (Hewlett-
Packard REDUX paste). The negative (reference) electrode
was sewn to the small region of myocardium supplied by
the nonoccluded diagonal branch of the LAD, while the
positive electrode was placed in the distribution of the
occluded arteries, usually on the left ventricular free wall,
near the apex. The electrodes were therefore 4-6 cm apart,
with the positive electrode lying at least 2 cm from the
perfused zone during coronary, occlusion. The electro-
grams were filtered by a 1000 Hz, low-pass active filter,
and drifted less than 300 fiv/5 min in the absence of
ischemia. The electrograms recorded during ischemia were
similar in amplitude and morphology to those obtained in.
previous studies involving unipolar recording (Kleber et
al., 1978; Janse et al., 1980). However, in our experiments,
placement of the reference electrode at an extra-cardiac
site gave injury potentials much lower in amplitude and
of variable morphology. This is presumably because the
nonischemic zone was too small to drive electrically the
remainder of the body, as it would in conventional re-
gional ischemia, where the infarct is much smaller. The
epicardial electrogram was recorded, together with aortic
pressure and a standard electrocardiographic lead (II), by
an optical strip chart recorder (Gould ES-100) at paper
speeds of 25-200 mm/sec. The epicardial electrograms
were displayed so that a positive deflection of the ischemic
zone electrode with respect to the reference (perfused
zone) electrode appeared upright.
Multiple control occlusions were performed in each dog
before drug infusion. Diltiazem (d-3-acetoxy-cis-2,3-di-
hydro-5-(2-dimethylamino)ethyl)-2-(p-methoxyphenyl-
l,5-benzothiazepin-4(5H)-orie hydrochloride; Marion
Laboratories) was diluted in 0.9% NaCl to a concentration
of 0.5 to 1.5 mg/ml and administered at a dose of 0.02
mg/kg per min for 25 minutes by a Harvard continuous
infusion pump. A 25-minute infusion at this rate was
previously shown to produce a mean serum diltiazem
concentration of 173 ±84 ng/ml, which declined expo-
nentially (T = 60 min) when the infusion was terminated
(Clusin et al., 1982).
In five dogs, coronary blood flow was measured by
injection of radionudide-labeled microspheres into the left
atrium (Heymann et al., 1977). Four sets of microspheres,
each bearing a different nuclide, were injected into each
animal. Two sets were injected prior to diltiazem admin-
istration: one set 3 minutes before coronary occlusion and
one set 30 seconds after occlusion. The other two sets
were injected before and after an occlusion performed at
the completion of the diltiazem infusion. Each injection
contained approximately 30 million 8 to 10 pm micros-
pheres labeled with I25I, 141Ce, "Cr, "Sr; wNb, or "Sc.
and was completed over 20 seconds without significant
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hemodynamic effect. A simultaneous timed blood collec-
tion of approximately 15 ml was made through the arterial
catheter over a 90-second period beginning 5 seconds
before each injection.
Hearts were excised after termination of the experiment
and fixed for 3-5 days in 10% formalin. Two cylindrical
transmural cores then were cut from the left ventricle,
using a 2.5-cm (i.d.) sharpened steel cylinder that had an
axial pin protruding beyond its cutting edge for centering.
Each myocardial core was concentric with one of the
epicardial electrode sites, and therefore included all of the
myocardium that had been within 1 on of that electrode.
Each core was cut into four transmural layers; epicardial,
endocardia!, and two mid-myocardial. The four layers of
each core were 2-5 mm thick, weighed at least 1.1 g, and
contained a minimum of 100 microspheres of the nuclides
administered before coronary occlusion. Radioactivity was
counted with a 1024 channel 7 well-counter (Packard
model 9012). Regional blood flow was calculated on a
digital computer by standard region-of-interest analysis
(Heymann et al., 1977). Mean blood flow (in ml/min per
g), was computed for each myocardial core, and for each
of the four layers that comprised it.
Data from the above experiments have been displayed
as mean ± so, except for the microsphere data, which
were displayed as mean ± SE, to conserve space. Mean VF
latencies were computed using a value of 420 seconds for
seven trials in which VF did not occur within this limit.
Statistical comparisons involving two observations per dog
were performed by paired Mest (two-tailed). Comparisons
involving more than two observations were performed
using the nonparametric Friedman test, which gives a x2
value for each analysis (Siegel, 1956). This test was espe-
cially suitable for the VF latency data because the effects
of inter-animal variation were eliminated, and because the
ranking procedure permitted simple handling of the trials
in which VF did not occur.
Results
Reproducibility of Injury Potentials during
Ischemia
The effects of ischemia on the DC epicardial elec-
trogram are shown in Figure 1A. Ischemia produced
a negative shift in the epicardial potential at QRS
onset, which is sometimes called T-Q depression,
and which we have called the diastolic injury poten-
tial, because an initial R wave was sometimes pres-
ent. The diastolic injury potential was usually evi-
dent within 15 seconds of coronary occlusion and
reached a mean value of 9.1 ± 2.7 mV after 150
seconds of ischemia (n = 8). True elevation of the T
wave also occurred. Finally, ischemia reversed the
polarity of the QRS complex, so that the predomi-
nantly negative deflection was replaced by a totally
positive one. This phenomenon has been described
previously (Kleber et al., 1978), and is due to delay
or failure of action potential propagation into the
ischemic myocardium (van Capelle and Janse, 1982).
The effects of ischemia on the electrograms de-
veloped with a characteristic time course> and were
fully reversible when the coronary snares were re-
leased (Fig. IB, left). The time course of the diastolic
injury potential during a control occlusion has been
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FIGURE 1. Effects of ischemia and diltiazem on the epicardial electro-
gram. Results shown in part A were obtained during a control
occlusion, and in part B, after infusion of diltiazem. The positive
electrode was placed within the ischemic zone, near the apex, while
the reference electrode was placed over a small nonischtmic region
supplied by a diagonal branch of the LAD. Traces were obtained
during right atrial pacing at 0 (left) and 135 seconds (right) of ischemia.
Diltiazem reduced the ischemia-induced depression of the pre-QKS
potential (diastolic injury potential), as well as the peak elevation of
the T wave above the baseline. The change in QRS polarity from
negative (downward) to positive (upward) was delayed by diltiazem,
indicating relative improvement of conduction in the ischemic myo-
cardium. In contrast, AV nodal conduction was slowed by diltiazem,
as seen from the increased stimulus to R wave (S-R) interval
plotted in Figure 2 (filled circles). Uniformity of the
injury potentials during successive control occlu-
sions, was demonstrated in two ways. In Figure 3,
the diastolic injury potential has been averaged for
six control occlusions in the same animal (filled
circles). The relatively small standard deviations
show that the injury potential at each point in time
was similar during each occlusion. In the lower curve
of Figure 5, the mean diastolic injury potential in
eight dogs after 150 seconds of ischemia was plotted
for each of five consecutive control occlusions, la-
beled C1-C5. The lack of significant variation dur-
ing these occlusions was confirmed by the Friedman
test(x = 1.9, df = 4, P = 0.7).
Effects of Diltiazem on Injury Potentials and
Arrhythmias
Diltiazem reduced the ischemic injury potentials
in every animal studied. Figure 1 compares epicar-
dial electrograms obtained at 135 seconds during
occlusions before (part A) and immediately after
(part B) diltiazem infusion (0.5 mg/kg over 25 min-
utes). Diltiazem reduced the diastolic injury poten-
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FIGURE 2. Effect of diltiazem on the time course of injury potential
development. The diastolic injury potential (in mV) was measured at
G-second intervals, and plotted as a function of time during occlu-
ions before (•> and immediately after fx) diltiazem. The injury
:'otential was reduced by diltiazem at every point up to the develop-
ment of VF (arrows). The magnitude of the injury potential at VF
'lift (circled symbols) was unchanged.
rial from 10.8 mV in part A to 7.0 mV in part B. The
>eak T wave elevation was also reduced, and atrio-
entricular conduction time (stimulus to R wave
uterval) was increased. As seen in Figure 2, dilti-
izem reduced the diastolic injury potential at every
soini in time up to the onset of VF. The injury
otential increased again 1 hour after termination of
he infusion (Fig. 3, open squares), when the serum
Diltiazem concentration would have declined e-fold
Clusin et al., 1982). Similar results were obtained
. - eight animals, giving the average data shown in
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x DILTIAZEM -,
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300
L'RE 3. Injury potential development during multiple control trials
• reversibility of the effect of diltiazem. The mean diastolic injury
ntial during six consecutive control occlusions has been plotted
^-second intervals (9). The relatively small standard deviations
;>r bars) indicate the reproducible time course of injury potential
•ilopment. The injury potentials were considerably smaller after
:iiizem infusion 0>0 than the control values, but had increased
'ftantially 1 hour later (O).
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Figure 4. The mean diastolic injury potential was
significantly reduced by diltiazem at every point in
time (P = 0.01 to 0.004). Even greater statistical
significance (P = 0.01 to 0.0003) was demonstrated
when the injury currents from each animal were
normalized (expressed as a percentage of the control
value at 150 seconds).
Reduction of the diastolic injury potential by dil-
tiazem was always associated with prevention of VF
during the period of observation (up to 420 seconds)
or with a delay in VF onset compared to the control
trials. The mean VF latency before and after dilti-
azem infusion has been plotted in the upper curve
of Figure 5. Diltiazem increased VF latency beyond
the five control values in all eight dogs, and in four
dogs, VF was prevented during the first post-drug
trial (Dl). Onset of less severe arrhythmias (ventric-
ular premature beats and unsustained ventricular
tachycardia) was also delayed by diltiazem, in agree-
ment with the findings of Patterson et al. (1983).
The changes in arrhythmia latency after diltiazem
infusion were similar to the changes in diastolic
injury potential (lower curve of Fig. 5). The mean
diastolic injury potential at 150 seconds (lower curve
of Fig. 5) was smaller after diltiazem infusion than
during any of the five control trials, and was slightly
smaller during the first post-drug trial (Dl) than the
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FIGURE 4. Mean diastolic injury potential and aortic systolic blood
pressure in eight dogs during coronary occlusions before W and
immediately after diltiazem fx)- The mean diastolic injury potential
(upper curves) was significantly larger during the control occlusions
at every point in time. Coronary occlusion produced a similar decline
in the mean aortic systolic pressure, before and after diltiazem dower
curves). .
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FIGURE 5. Mean VF latency and diastolic injury potential in eight
dogs before and after diltiazem. Measurements were obtained during
five control occlusions (C1-C5) and two occlusions after diltiazem
infusion (D1-D2). Mean VF latency (upper curve) was relatively
constant during the control trials, increased markedly after diltiazem,
and declined somewhat during the second post-drug trial (D2). Error
bars were omitted for the post-drug trials because VF sometimes failed
to occur within the maximum observation period of 420 seconds. The
mean diastolic injury potential at 150 seconds of ischemia was plotted
for the same occlusions in the lower curve. The injury potential was
markedly reduced immediately after diltiazem (Dl) and somewhat
less so during the second post-drug trial (D2)
second (D2). The statistical significance of these
results was corroborated when all seven trials were
analyzed by the Friedman test (x2 = 35.1 for VF
latency; 33.1 for injury potential, df = 6, P < 10~5
for both curves).
Failure of Diltiazem to Restore Perfusion to the
Ischemic Zone
Reduction of the diastolic injury potential by dil-
tiazem could have resulted from drug-induced res-
titution of coronary perfusion near the ischemic zone
electrode, or from a flow-independent reduction of
cellular depolarization. The first possibility was in-
tentionally minimized by the experimental design,
and was directly tested in five of the eight dogs by
infusion of radionuclide^labeled microspheres for
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measurements of regional blood flow. The diameter
of the myocardial specimens analyzed was 2 cm
larger than the electrode diameter, and was also
large, compared with the electrical space constant of
ventricular muscle. Any myocardium which could
have influenced the electrograms was therefore in-
cluded in the blood flow measurements.
The effects of coronary occlusion and diltiazem
on blood flow near the electrode sites are shown in
Figure 6. Prior to diltiazem (filled circles), coronary
occlusion reduced blood flow to the ischemic zone
specimens for a basal level of 0.86 ± 0.10 ml/min
per g to an insignificant level of 0.05 ± 0.02 ml/min
per g (P = 0.001). A smaller reduction in flow
occurred in the perfused zone specimens, due either
to overlap of the specimens with ischemic myocar-
dium, or to the decline in aortic blood pressure
during ischemia. Diltiazem produced an 11% in-
crease in blood flow to the ischemic zone specimens
prior to coronary occlusion (P = 0.03), and a com-
parable increase in flow to the perfused zone spec-
imens. However, there was no significant change in
flow to the ischemic specimens subsequent to occlu-
sion (P = 0.4).
Because extracellular electrodes are most sensitive
to depolarization in nearby tissue, diltiazem might
have diminished the injury potentials by causing
redistribution of residual coronary flow toward the
epicardium. This possibility was excluded by com-
putation of flow to each of the four layers that
comprised each myocardial specimen. After dilti-
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FIGURE 6. Effects of diltiazem and coronary occlusion on blood flow
near the epicardial electrode sites in five dogs. Regional blood flow
was calculated from measurements of microsphere-bound radioactiv-
ity in transmural cores centered around the ischemic zone (left) and
perfused zone (right) electrode sites. Microspheres labeled with differ-
ent nuclides were infused before and after coronary occlusion in the
presence (x) and absence (•) of diltiazem. Coronary occlusion reduced
flow in the ischemic zone nearly to zero, and produced a smaller
reduction in the perfused zone. Diltiazem produced a small increase
in flow to the perfused zone, and to the ischemic zone prior to
coronary occlusion, but did not appreciably alter flow to the ischemic
zone during occlusion.
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FIGURE 7. Failure of diltiazem to alter the injury potential at VF. The diastolic injury potential at VF onset was plotted on the vertical axis, and
the corresponding duration of ischemia (VF latency) on the horizontal axis. The three control occlusions preceding drug infusion were compared
with the first two post-drug occlusions in which VF occurred (circled symbols). Each injury potential was expressed as a percentage of the mean
of the control values for that dog. VF was invariably delayed by diltiazem, but the injury potential at VF onset remained within the control range.
Data are from the same dogs as in Figures 4-5, except that two dogs were excluded in which VF did not occur during the several occlusions after
diltiazem infusion.
azem infusion, the postocclusion flow to the epicar-
dial layer of the ischemic zone specimen was <0.05
ml/min per g in each of the five dogs (mean value
= 0.03 ± 0-01 ml/min per g).
To confirm that the regional blood flow measure-
ments were directly pertinent to the electrophysio-
logical findings, the mean diastolic injury potential
was computed for the subgroup of five animals in
which blood flow was also measured. The normal-
ized injury potentials were significantly smaller after
diltiazem at every point in time (P = 0.01 to 0.003).
Reduction of these potentials by diltiazem was
therefore not due to increased perfusion near the
ischemic zone electrode.
Constancy of the Injury Potential at VF Onset
Depolarization of ischemic myocardial cells is be-
lieved to cause ischemic arrhythmias directly, either
by inducing ventricular automaticity (Katzung et al.,
1975) or by producing sufficient slowing of conduc-
tion to permit reentry. If the increase in VF latency
by diltiazem were due entirely to slowing of is-
chemia-induced depolarization, then the magnitude
of the diastolic injury potential at VF onset would
not be altered by the drug. This prediction was born
out in Figure 2, where the diastolic injury potential
at VF was identical before and after diltiazem. To
test the generality of this observation, the diastolic
injury potential was plotted as a function of VF
latency for six dogs in which VF recurred after
diltiazem infusion (Fig. 7). Injury potentials were
normalized to the mean of the control values to
facilitate comparison among dogs. Although the VF
latency after diltiazem (circled symbols) always ex-
ceeded the control values, the diastolic injury poten-
tial at VF onset remained within the control range.
The mean diastolic injury potential at VF was 10.0
± 2.7 mV for the 18 control occlusions in Figure 7,
compared with 9.6 ± 2.5 mV for the 12 occlusions
performed after drug infusion (P = 0.7). Thus, the
degree of depolarization near the ischemic zone
electrode at the onset of VF was not significantly
altered.
Effect of Diltiazem on the Ischemia-Induced
Conduction Delay
The apparent relation between ischemia-induced
depolarization and VF could reflect the fact that
depolarization slows conduction within the ischemic
zone by causing inactivation of fast sodium chan-
nels. Although the epicardial electrograms did not
permit direct measurement of conduction velocity,
the effect of ischemia on conduction could be in-
ferred from the change in the morphology of the
QRS complex. In every control recording, the initial
QRS complexes contained a large negative deflec-
tion, which was abolished or greatly diminished
after 150 seconds of ischemia, leaving a predomi-
nantly or totally positive deflection. In five of the
eight dogs, the negative deflection was initially
larger than any positive deflection, so that there was
overall reversal of QRS polarity during ischemia
(e.g., Fig. 1A). As noted above, the ischemic zone
electrode was usually located near the LV apex,
whereas the perfused zone electrode was on the free
wall near the AV groove. The predominant negativ-
ity of the QRS complex prior to ischemia was there-
fore in accordance with the normal ventricular acti-
vation sequence, and its reversal during ischemia
was an expected result of impaired conduction
•
I: F
within the ischemic zone (Kleber et al., 1978; van
Capelle and Janse, 1982).
The changes in QRS morphology produced by
ischemia were highly reproducible during successive
control occlusions. In Figure 8, the amplitude of the
largest QRS deflection (measured with respect to the
pre-QRS potential) has been determined at 15-sec-
ond intervals during five consecutive control occlu-
sions, giving the average values plotted as filled
circles. The relatively small standard deviations
show that the changes in the QRS complex were
similar during each occlusion. Diltiazem greatly de-
layed the effects of ischemia oh ventricular conduc-
tion. In Figure IB, the QRS complex after 135 sec-
onds of ischemia was predominantly negative, even
though it was totally positive in the control recording
(Fig. 1A). As seen in Figure 8, reversal of the QRS
polarity was not prevented by diltiazem, but was
substantially delayed.
The effects of ischemia and diltiazem on ventric-
ular conduction could be compared more simply by
measuring the duration of coronary occlusion nec-
essary to convert the QRS complex from predomi-
nantly negative (largest deflection negative) to pre-
dominantly positive. This time interval, which we
have called the activation reversal latency, was de-
termined for each of the five dogs in which a pre-
dominantly negative QRS was initially present, giv-
ing the mean values plotted in the upper curve of
Figure 9. The mean activation reversal latency was
nearly constant during the five control occlusions
(C1-C5), but increased beyond the control range in
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FIGURE 8. Changes in peak QRS potential during serial coronary
occlusions before after diltiazem. The largest deflection of the epicar-
dial QRS complex was measured at 15-second' intervals during six
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reversal of QRS polarity occurred with a nearly uniform time course
during the control trials, as shown by the standard deviations (error
bars), but was markedly delayed by diltiazem 00. A value of zero was
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FIGURE 9. Effect of diltiazem on ischemia-induced QRS reversal
(activation reversal). The duration of coronary occlusion at which the
positive QRS deflection first exceeded the largest negative deflection
was determined in five dogs whose preocclusion electrograms con-
tained predominantly negative QRS complexes. Mean values were
plotted in the upper curve for five control occlusions (Cl-CS) and
two occlusions after diltiazem (D1-D2). Activation reversal occurred '
at nearly constant latency during control trials, but was significantly
delayed by diltiazem. The diastolic injury potential at the moment of
activation reversal was also determined, giving the mean values in
the lower curve. The injury potential at activation reversal was nearly
constant before and after diltiazem.
each of the five dogs after diltiazem infusion. The
changes in activation reversal latency were highly,
significant by the Friedman test (x2 — 20.7, df = 6,
P = 0.002). A separate analysis of the five control
occlusions showed no significant variation (x2 = 3.6,
df = 4, P = 0.5).
If the preservation of normal ventricular conduc-
tion by diltiazem were purely a result of reduced
depolarization, then the degree of depolarization
needed to produce a pre-defined conduction im-
pairment would not be altered by the drug. This
relationship was studied by measuring the diastolic
injury potential at the moment of activation reversal
for each of the trials in Figure 9. Although injury
potential development and activation reversal were
both delayed by diltiazem, the mean injury potential
at the time of activation reversal (lower curve) was
virtually unchanged. The absence of significant var-
iation during the seven occlusions was confirmed
by the Friedman test (x2 = 0.01, df = 6, P = 0.99).
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Discussion
Early arrhythmias during coronary occlusion ul-
timately result from effects of ischemia on the ven-
tricular resting and action potential. Rapid changes
in transmembrane potential'have been observed in
intracellular recordings from infarcts (FGeber et al.,
1978; Janse et al., 1980), and are faithfully reflected
by the 'injury* potentials simultaneously recorded
from the epicardial surface. Van Capelle and Janse
(1982) have examined the reprodutibility of these
phenomena in a small number of animals in which
microelectrode impalements could be maintained
during multiple occlusions. They find that the effects
of ischemia on membrane potential occur with a
reproducible time course during at least three con-
secutive trials.
In the present study, the uniform time course of
ischemic injury potentials enables us to demonstrate
reduction of these potentials by diltiazem, and to
correlate this effect with delay or prevention of
ventricular fibrillation. The injury potentials, and
changes in QRS potential that we record are similar
in amplitude and time course to those seen in con-
ventional regional ischemia. However, our results
have been obtained under conditions approaching
global LV ischemia, where arrhythmia onset occurs
predictably during brief ischemic episodes (Clusin
et al., 1982). The key innovation which makes this
possible is the use of a differential recording config-
uration that gives full-sized injury potentials, despite
the extremely small size of the nonischemic region.
S-T Segments and Infarct Size
Improvement of ischemia-induced S-T changes
by a drug is often equated with reduction of myo-
cardial infarct size, although the validity of this
inference has been questioned (Fozzard and Das
Gupta, 1976). In our experiments, this interpretation
has been excluded by measurement of residual
blood flow over a region several electrical space
constants larger than the epicardial electrodes. The
residual flow to the ischemic myocardium before
and after diltiazem is comparable to that measured
in pig hearts, which lack intercoronary collaterals
(Fujiwara et al., 1982), and is consistent with the
profound reduction of coronary venous flow that
we previously observed after combined LAD and
circumflex artery occlusion (Gusin et al., 1982). In
some dogs, residual flow near the ischemic zone
electrode becomes undetectable during the coronary
occlusions. The effects of diltiazem on the injury
potentials are no different in these cases, than in
dogs with a non-zero residual flow. Three features
of our model presumably account for the low levels
of residual coronary flow: (1) the brevity of the
occlusions, (2) the small size of the perfused zone,
and (3) deliberate placement of the ischemic elec-
trode as far as possible from perfused myocardium.
Our results do not exclude possible enlargement
of the nonischemic region by diltiazem. Such an
effect would.be consistent with the observed in-
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crease in postocclusion flow near the perfused zone
electrode (Fig. 6, right). However, because of the
configuration of the recordings, an increase in per-
fusion near this electrode could only increase the
amplitude of the injury potentials. The observed
reduction of these potentials must therefore involve
a direct effect of diltiazem on the ischemic myocar-
dium.
The ability of calcium channel blockade to dimin-
ish the characteristic effects of ischemia through a
flow-independent mechanism has been demon-
strated in intracellular recordings from isolated dog
ventricular strips during brief superfusions with hy-
poxic, potassium-rich, acidic saline (Kimura et al.,
1982). In these experiments, the effects of the altered
saline developed with a reproducible time course
during successive trials in the same preparation.
Pretreatment with verapamil caused relative pres-
ervation of epicardial action potential amplitude,
upstroke velocity and conduction velocity at 5 and
10 minutes of simulated ischemia.
Metabolic Considerations
A second means by which diltiazem might slow
the development of ischemic injury potentials is
through reduction of energy expended as mechani-
cal work. We have measured the hemodynamic
effects on an identical diltiazem infusion, and find
that, whereas the mean aortic pressure during is-
chemia is unchanged, the cardiac output increases
significantly, presumably in response to peripheral
vasodilation (Clusin et al., 1982). Thus, in our
model, mechanical energy expenditure is increased
rather than decreased by diltiazem. Although we
did not measure cardiac output in the present study,
the failure of diltiazem to alter aortic blood pressure
(Fig. 4, lower curves) suggests that its effects on
cardiac work were as previously found.
There is a variety of evidence that the 'protective
effect* of calcium channel blockers during ischemia
need not be contingent upon an increase in myocar-
dial energy stores. Jolly et al., (1981) found that the
more complete recovery of contractile function in
diltiazem-treated guinea pig hearts after ischemia is
not associated with an increase in high energy phos-
phate stores during ischemia. Thandroyen (1982)
found that the antifibrillatory effect of diltiazem
could be observed in the absence of increased high
energy phosphates. Finally, Henry and Wahl (1983)
found that diltiazem doubles the duration of hy-
poxia needed to produce contracture in quiescent
ventricular muscle. This protective effect is not due
to reduction of systolic force, since no phasic con-
tractions occur.
Does Calcium Overload Directly Affect
Membrane Potential?
A third explanation for the reduction of ischemic
depolarization by diltiazem is that depolarization
occurs as a direct consequence of intracellular cal-
cium overload, which develops rapidly during met-
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abolic inhibition (Dahl and Isenberg, 1980), and
ischemia (Katz and Reuter, 1979; Clusin et al., 1983).
Cardiac cells are known to contain inward current
channels that are opened exclusively by the presence
of calcium ions at the inner surface of the cell
membrane (Colquhoun et al., 1981). Moreover, ex-
trusion of calcium across the surface membrane in
exchange for sodium may involve net inward move-
ment of positive charge (Mullins, 1979). These
mechanisms are believed to produce the transient
inward current (TI) of digitalis toxicity (Kass et al.,
1978a, 1978b), which occurs when sequestered cal-
cium is inappropriately released during diastole. A
similar process may occur in ischemia, due to the
energy requirement for calcium sequestration. Clu-
sin X1983b) has shown that exposure of voltage-
clamped cardiac cells to metabolic inhibitors elicits
a depolarizing inward current which is suppressed
by removal of external calcium, and has several
other features in common with the digitalis-induced
TI. A similar, though less sustained, depolarizing
current is induced by 10 HIM caffeine, which causes
calcium release from the sarcoplasmic reticulum
(Clusin, 1983a).
Calcium overload may also lead to shortening of
the cardiac action potential during ischemia. Action
potential shortening is observed in several condi-
tions that increase intracellular calcium, including
digitalis toxicity, increased beat frequency, increased
extracellular calcium, and intracellular injection of
calcium with microelectrodes (Isenberg, 1977; Ku-
rachi, 1982). In digitalis toxicity, the shortening of
the action potential can be reversed by intracellular
injection of EGTA (Matsuda et al., 1982). A direct
role of intracellular calcium would be consistent with
our observation that diltiazem reduces true S-T ele-
vation during ischemia, although changes in con-
duction might also affect T wave morphology in our
experiments.
Prevention of calcium overload could diminish
other effects of ischemia that can influence the
resting and action potential. Increased extracellular
potassium, for example, is at least partly responsible
for the early reduction of the resting potential during
coronary occlusion (Hill and Gettes, 1989; Kleber,
1983). Since calcium-activated channels in cardiac
cells are permeable to postassium (Colquhoun et al.,
1981), prevention of calcium overload could dimin-
ish potassium efflux during ischemia. Acidosis may
also contribute to the electrophsiological effects of
ischemia (Morena et al., 1980; Gilmour and Zipes,
1980; Kagiyama et al., 1982). Kurachi (1982) has
recently shown that the effects of intracellular pro-
ton injection on the action potential and membrane
current of ventricular cells are similar to those of
calcium injection. He ascribes this similarity to a
reversible exchange of intracellular protons for se-
questered calcium ions, which has also been pro-
posed by Vaughan-Jones et al. (1983). Changes in
the action potential during acidification could there-
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fore be due, at least in part, to effects of liberated
intracellular calcium on membrane permeability.
Moreover, prevention of calcium overload by a drug
might diminish cytoplasmic acidification during is-
chemia.
The Relation of Ischemic Depolarization to
Conduction Changes and Arrhythmias
Diltiazem's ability to preserve normal action po-
tential characteristics during ischemia may explain
the prolongation of arrhythmia latency by this drug.
There are two ways in which reduction of ischemic
depolarization could retard arrhythmias. First, Kat-
zung et al., (1975) suggest that ischemic depolari-
zation and the resulting diastolic injury current in-
duce ventricular automaticity. Their hypothesis is
consistent with the fact that the first beat of ventric-
ular fibrillation arises in normal myocardium near
the ischemic boundary (Janse et al., 1980; Ideker et
al., 1981). Since depolarization-induced automatic-
ity occurs at a reproducible stimulus strength, this
mechanism could explain why the diastolic injury
potential at the onset of VF remains constant after
diltiazem (Fig. 7). Alternatively, VF may be a con-
sequence of slowed conduction within the ischemic
zone. Reduction of ischemia-induced conduction de-
lay has been demonstrated previously with verapa-
mil (Elharrar et al., 1977), diltiazem (Peter et al.,
1982), and nifedipine (Nakaya et al., 1981), and has
been implicated in the suppression of early arrhyth-
mias (Elharrar et al., 1977).
Improvement of conduction by calcium channel
blockers is considered paradoxical because, in de-
polarized fibers, calcium channel blockade should
impair conduction further. Four mechanisms could
account for improvement of conduction by these
drugs: (1) The improvement observed by Peter et al.
(1981) may have been due to reduction of infarct
size because conduction was improved by a rela-
tively constant amount during 30 minutes of is-
chemia, and because the nonoccluded blood supply
was extensive. This explanation is unlikely becauset
in our study there was negligible blood flow near
the ischemic electrodes, and only short-term pres-
ervation of conduction. (2) Diltiazem might have
improved conduction by causing reflex-mediated
catecholamine release (Danilo et al., 1978). Al-
though we have no evidence against this hypothesis,
it probably is not the primary mechanism, since
reduction of injury potentials by propranolol is ac-
companied by a similar improvement in conduction
(Clusin and Buchbinder, unpublished observations).
(3) Improved conduction could be due to increased
sodium channel availability as a result of reduced
depolarization. This mechanism undoubtedly ac-
counts for at least some of the conduction improve-
ment which we observe, because the diastolic injury
potential was diminished at the same electrode sites
where conduction was studied. (4) Diltiazem might
improve conduction by causing a relative increase
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in membrane resistance during ischemia. Hypoxia
(Mascher and Carmeliet, 1975) and metabolic inhib-
itors (Clusin, 1983b) both decrease membrane re-
sistance in cardiac cells, even when membrane po-
tential is held constant. Ischemia could have similar
effects, since it causes greater conduction delay than
equivalent depolarization by potassium (Hill and
Gettes, 1980; Morena et al., 1980). If the resistance
decrease in the above conditions is mediated by
calcium-activated ion channels (Clusin, 1983b), then
prevention of calcium overload would necessarily
improve conduction.
Can Preservation of Action Potential
Characteristics Lead to Arrhythmia Prevention?
An important question raised by our observations
is whether the slowing of ischemic depolarization
by diltiazem would prevent VF or merely delay its
onset. In dogs, lethal arrhythmias seldom occur
more than 20 minutes after coronary occlusion (Ka-
plinsky et al., 1979). Later onset of VF may be
prevented by electrical uncoupling (van Capelle and
Janse, 1982) or by spontaneous improvement of
action potential characteristics (Morena et al., 1980;
Gilmour and Zipes, 1980). Whatever the reason for
the limited period of vulnerability, preservation of
the resting and action potential during this period
could potentially prevent arrhythmias, even if no
myocardium were ultimately salvaged.
Diltiazem rarely prevents VF during global LV
ischemia, even though VF latency may increase
several-fold (Clusin et al., 1982). In contrast, dilti-
azem can abolish VF when only the LAD is occluded
(no VF in 6/6 dogs; Schnittger et al., unpublished
data), as can verapamil (Kaumann and Aramendia,
1968). Since the majority of VF episodes produced
by LAD occlusion in untreated dogs occur between
13 and 20 minutes of ischemia (Kaplinsky et al.,
1979), a moderate increase in VF latency by dilti-
azem could, in this situation, cause the usual period
of vulnerability to be exceeded. 1
It is uncertain whether similar protective effects
occur in the clinical setting. In patients with angina,
diltiazem, at serum concentrations similar to those
used here, increases the duration of treadmill exer-
cise needed to produce S-T segment depression
(Hung et al., 1982), and increases the work load at
which criterion S-T segment depression is achieved
(Wagniart et al., 1982). This latter finding seems
consistent with our conclusion that diltiazem retards
the effects of ischemia on the action potential, even
when the extent and severity of ischemia are un-
changed.
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REDUCTION OF ISCHEMIC DEPOLARIZATION
BY DILTIAZEM: A FLOW-INDEPENDENT EFFECT
William T. Clusin, Maurice Buchbinder, Avery K. Ellis,
Robert S. Kernoff, John C. Giacomini, Donald C. Harri-
son-. Cardiology Division; Stanford U; Stanford CA
Ischemic depolarization and arrhythmias may result
(torn effects of Ca overload on membrane permeability.
We therefore compared the effects of diltiazem (D) on
ischemic injury potentials and ventricular fibrillation
(VF) during serial coronary artery occlusions in dogs.
Injury potentials and VF were elicited every IS min by
simultaneous occlusion of the LAD and circumflex
arteries during rapid a trial pacing. DC epicardial elec-
trograms were recorded differentially between the is-
chemic zone and the distribution of a non-occluded
proximal branch of the LAD. Injury potentials devel-
oped with a uniform time course during 5 control trials,
but were reduced by D infusion (0.5-.mg/kg) in 8 dogs. D
reduced the mean T-Q depression at ISO sec of ischemia
from 9.1+2.7 mV to 6.W.6 mV (1*0.001). D increased
the mean time from coronary occlusion to VF from 186
to 366 sec (P<X) ), but did not change T-Q depression
at VF onset. D also delayed ischemia-induced conduc-
tion impairment to the same extent as T-Q depression.
In 5 dogs, the effect of D on blood flow near the
epicardial electrodes was measured using radioactive
microspheres. Coronary occlusion reduced flow to the
ischemic zone from 0.86 to 0.05 cc/min/g (P=0.001). D
increased pre-occluslon flow by 11% (P=OJ33), but did
not significantly alter flow during occlusion. D did not
diminish cardiac work. D therefore produced a flow-
independent reduction of cellular depolarization during
ischemia, which may reflect reduction of Ca overload.
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EFFECTS OF INCREASED RIGHT VENTRICULAR PRESSURE ON CORONAH
BLOOD FLOW DISTRIBUTION. Avery K. Ellis». John C. Giacomi
Robert Kernoff*. Donald C. Harrison. Stanford University
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We studied the effects of acute changes in right ventri
lar systolic pressure (RVSP) on coronary blood flow distri
tion in ten open-chest mongrel dogs. Measurements were mad
using radioactive microspheres at three levels of RV3?:-cp
trol, 31 + 1.5 .(SSH) .EinHg; moderate RVSP- elevation^ 55'+"-
2.0 rni&Hg, produced by constriction of the sain pulmonary
artery (M?A); and marked RVS? elevation", 80^ 3.5 osEs,. pr
duced by further M?A constriction. With intact autoregulat
basal flow to the RV free wall averaged 0.76 + 0.10 ral/min
The ratio of endocardial flow to epicardial flow (endo-epi
ratio) was 1.05 + 0.06, and both overall flow and endo-epi
ratio remained unchanged with increased RVSP. With maxima
coronary .vasodilation produced by carbocromen (5 mg/kg),
overall RV flow increased to 4.5^  £ 0.49 ml/min/g. The en
repl": ratio ave'raged -0.98 F£ JD .08 with-rnaximal -va^ odi-latiorv -
"at control RVSP, "6.91 ±0.06 with moderate'RVSP "elevation,
and 0.70 + 0.06 (p < 0.01) with marked RVSP elevation. We
conclude that, with intact autoregulation, normal coronary
reserve mechanisms can adequately-maintain RV subendocardi
flow despite a marked increase in systolic compresaive for
With maximal vasodilation, however, local flow reflects tfc
interaction of driving pressure and local compressive fore
and elevations in RVSP result in a diminution of RV subend
cardial blood flow. (Supported in part by NASA NCC2-126".)
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